Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

Erythropoiesis-stimulating agents (ESAs) increase red blood cell (RBC) production in bone marrow by activating the erythropoietin receptor (EpoR) on erythrocytic-progenitor cells. Erythropoiesis-stimulating agents are approved in the United States and Europe for treating anaemia in cancer patients r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Aapro, M, Jelkmann, W, Constantinescu, S N, Leyland-Jones, B
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2012
Soggetti:
Minireview
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3314780/
https://ncbi.nlm.nih.gov/pubmed/22395661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.42
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi